Skip to content

Clinical trials

Prostatic Neoplasms, Castration-Resistant trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms, Castration-Resistant Country / region: France Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20172
20192
20201
20221
20233
20244
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9
Terminated3
Completed2
Active, not recruiting2
Not yet recruiting1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC4
Bristol-Myers Squibb2
Hoffmann-La Roche2
MacroGenics2
Merck Sharp & Dohme LLC2
Novartis Pharmaceuticals2
Celcuity Inc1
Centre Henri Becquerel1
Institut Claudius Regaud1
T.O.A.D. Oncology SA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms, Castration-Resistant19
Prostatic Neoplasms4
Neoplasms3
Lymphoma, Non-Hodgkin2
Neoplasm Metastasis2
Anus Neoplasms1
Carcinoma1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Small Cell1
Endometrial Neoplasms1

Trials

Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.